GCRI to offer clinical trials of CAR-T cancer therapy
Ahmedabad Mirror|December 19, 2024
The trials will start once the hospital gets nod from DCGI; the therapy uses patient's immune system to fight cancer cells
Ankit Pandey
GCRI to offer clinical trials of CAR-T cancer therapy

The Gujarat Cancer Research Institute (GCRI) at Medicity Ahmedabad, is set to start clinical trials for CAR-T cell therapy in the next three to four months. The trials, awaiting approval from the Drug Controller General of India (DCGI), will be free of cost for the patients, according to GCRI sources.

This story is from the December 19, 2024 edition of Ahmedabad Mirror.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the December 19, 2024 edition of Ahmedabad Mirror.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM AHMEDABAD MIRRORView All